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We report a case of frontotemporal dementia caused by a novel MAPT mutation (Q351R) with a remarkably
long amnestic presentation mimicking familial Alzheimer’s disease. Longitudinal clinical, neuropsychological and
imaging data provide convergent evidence for predominantly bilateral anterior medial temporal lobe involvement
consistent with previously established neuroanatomical signatures of MAPT mutations. This case supports the
notion that the neural network affected in MAPT mutations is determined to a large extent by the underlying
molecular pathology. We discuss the diagnostic significance of anomia in the context of atypical amnesia and the
impact of impaired episodic and semantic memory systems on autobiographical memory.
Keywords: Episodic memory; Semantic memory; Familial Alzheimer’s disease;MAPT mutations; Frontotemporal
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Frontotemporal dementia (FTD) is a common
cause of young onset dementia (Harvey, Skelton-
Robinson, & Rossor, 2003; Ratnavalli, Brayne,
Dawson, & Hodges, 2002). Around a third to a
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half of patients with FTD have a family history
with approximately 10–40% following an autoso-
mal dominant inheritance pattern (Bird et al., 2003;
Chow, Miller, Hayashi, & Geschwind, 1999; Rohrer
© 2013 The Author(s). Published by Taylor & Francis.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. The moral rights of the named author(s) have been asserted.
LESSONS FROM A NOVEL MAPT MUTATION CASE 685
et al., 2009). MAPT, PGN, and C9ORF72 muta-
tions have been identified as three major genetic
causes. Studying patients with genetic forms of
FTD can reveal potential relationships between
specific molecular pathologies and clinical pheno-
types which could in turn be helpful in elucidating
the underlying disease mechanisms. MAPT muta-
tions typically present with behavioral changes with
subsequent emergence of semantic deficits, mem-
ory decline, and motor features (Rohrer & Warren,
2011). Occasionally one of the nonbehavioral fea-
tures predominates, resulting in patients receiving
an alternative diagnosis initially.We report a patient
who presented with a remarkably long history of
amnesia with early features of semantic loss fol-
lowed later by behavioral changes.
CASE DESCRIPTION
CW (initials changed to preserve anonymity) is
a right-handed lady who was born at term and
reached normal developmental milestones. She
completed a university degree and worked at a rela-
tively senior level in the public sector. In her mid-
40s, her work performance deteriorated. Around
the same time, she became irritable and argumen-
tative leading to strained relationships with her
partner and children. With hindsight, her now for-
mer partner reports a subtle decline in her memory
from her late thirties.
She was first seen in our cognitive disorders clinic
at the age of 49 years old, with a principal com-
plaint of poor memory. She was forgetting appoint-
ments and had started to keep a diary. She had been
subjected to three separate capability assessments
at work. In addition to relationship difficulties,
there were also financial problems. She had had
some depressive symptoms including low mood, an
exaggeration of premorbid pessimism, and dimin-
ished interest and drive. General and neurological
examinations were normal.
As detailed in Table 1, the first neuropsycho-
logical assessment showed a mild reduction in
general intellectual function (FSIQ108 compared
with NART-estimated FSIQ 118) (Nelson, 1982;
Wechsler, 1981) with impaired performance on both
verbal and visual versions of the recognition mem-
ory test (RMT both <5th percentile) (Warrington,
1984). Confrontation naming was poor (graded
naming test (GNT): 5th percentile; Oldfield naming
test: 25–50th percentile) (McKenna & Warrington,
1983; Oldfield & Wingfield, 1965) which, together
with slightly reduced category fluency (animal
names: 25th percentile) (Spreen & Strauss, 1998),
hinted at early semantic impairment, especially in
comparison with preserved phonemic fluency (“s”:
>90th percentile) (Spreen & Strauss, 1998). The lat-
ter indicated preserved executive function as did
sound cognitive estimates (50th percentile) (Shallice
& Evans, 1978). Visual processing was intact (VOSP
TABLE 1
Select neuropsychology results at baseline, 8-year and 13-year follow-up visits
Session Full-scale IQ
Recognition memory
test (words)
Recognition
memory test
(faces)
WMS-delayed
story recall Rey complex figure recall
Baseline 108 36 (<5%) 35 (<5%) − −
8 yr 102 32 (<5%) 20 (<5%) 0 (<1%) 0 (<1%)
13 yr 86 27 (<5%) 25 (<5%) 0 (<1%) 0 (<1%)
Session
Graded naming
test
Famous
faces
Category
fluency
Letter
fluency
Synonym-matching
Concrete Abstract
Baseline 5 (5%) − 17 (25%) 21 (>90%) − −
8 yr 2 (<1%) 2 9 (<10%) 17 (50–70%) − −
13 yr 0 (<1%) 0 4 (<1%) 15 (44%) 16 (<1%) 18 (10%)
Session
Trail making
test B
Stroop inhibition Cognitive estimate
Baseline − − 3 (50%)
8 yr 140′ ′ (10–25%) 20–24% −
13 yr 146′ ′ (10–25%) 25–50% 15 (<1%)
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Figure 1. Mid-temporal axial volumetric T1-weightedMR images acquired at initial presentation and subsequent repeat visits (1-, 2-, 4-,
10-, and 12-year follow-up). All repeat images have undergone 12 degrees of freedom registration to spatially align them to the baseline
(Bl).
incomplete letters: >5th percentile) (Warrington
& James, 1991). Notwithstanding some reduced
scores, inconsistencies were noted between poor
naming, fluent spontaneous speech, and preserved
vocabulary score on the WAIS-R; and between
poor memory scores and her ability to pro-
vide details regarding her present circumstances.
In addition, she showed no implicit learning on the
Gollin figures test (Gollin, 1960). These factors, in
the context of her relatively young age and reported
changes in mood, suggested depression and addi-
tional functional component as possible causes for
her cognitive problems. However, her MRI brain
scan (Figure 1) showed small medial temporal lobes
for age.
DISEASE PROGRESSION
The clinical impression that depression was a signif-
icant contributor to her cognitive complaints was
revised 2 years later when, at the age of 51 years
old, CW’s memory had deteriorated significantly
and she had had to give up work. She would
now frequently forget the previous day’s events and
had difficulty finding familiar places while driv-
ing. Treatment with Citalopram for low mood and
anxiety had had no impact on her cognitive func-
tion. At this point, a more detailed family history
emerged. CW’s father had developed apathy at the
age of 39 years old followed by progressive memory
decline. He died at the age of 55 years old. Two of
his three siblings were similarly affected.
Further investigations were performed.
Cerebrospinal fluid was normal for cell counts,
protein and glucose. S100 was 0.96 ng/ml (refer-
ence range: 99% below 0.55 ng/ml). Oligoclonal
bands were negative in the CSF and serum. Tau
and Aβ42 levels were not available. EEG demon-
strated normal alpha rhythm with no epileptic
activity. Repeat MRI brain appeared to show stable
intracranial appearances but was now reported
to be consistent with Alzheimer’s disease (AD)
(Figure 1). A provisional diagnosis of AD was
made. On account of the strong family history, she
was screened for mutations in the PSEN1, 2 and
APP genes which were all negative.
Continuing cognitive deterioration followed in
the succeeding years such that by 57 years of age,
8 years after the initial presentation, she required a
support worker to assist with daily tasks. In addi-
tion to poor memory, occasional word-finding dif-
ficulties, the onset of a sweet tooth, and some
weight gain were reported. She tended to oversleep,
even during the day. She was no longer oriented in
time. There was further decline in naming (GNT:
2/30, <1st percentile; Oldfield Naming test: 16/30,
10–25th percentile) and semantic fluency (animal
names: <10th percentile) with a milder deterio-
ration in phonemic fluency (50–70th percentile).
There was mild executive impairment (trail mak-
ing part B: 10–25th percentile; stroop inhibition:
20–24th percentile) (Table 1). At this time, the
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profile comprising profound episodic and seman-
tic memory loss together with milder executive
problems was still thought to be consistent with a
diagnosis of early onset AD. There was now the
intimation of behavioral changes including some
disinhibition on the letter fluency task in the form
of sex-related words in addition to the change in
eating habits.
Clear behavioral symptoms emerged when CW
was 61 years old. She had become disinhibited and
frequently gave strangers her phone number and
address. She was increasingly apathetic and would
lie in bed all day unless prompted and needed
encouragement even to attend social functions
that she continued to enjoy. She had become less
empathic. Her intake of sweet food had increased
and she had developed musicophilia. The latter
took the form of listening to certain types of music
continually. She was started on Donepezil to no
great effect.
At this point, her baseline MRI and 4- and 10-
year repeat scans were spatially aligned using a
12 degrees of freedom (d.o.f.) registration as part
of her radiological review. This procedure allows
regions of cortical change between timepoints to
be quantified using the boundary shift integral
(BSI) and aids in visual assessment of volume loss
(Freeborough & Fox, 1997; Leung et al., 2010).
Review of these registered images indicated a pro-
gression in the anterior–posterior gradient of vol-
ume loss across the medial temporal lobes with
disproportionate loss anteriorly. This raised the
possible diagnosis of familial FTD due to a tau
mutation. She underwent another lumbar punc-
ture and the CSF analysis revealed a tau level of
429 pg/ml (suggestive of neurodegeneration) (local
reference range: abnormal >400 pg/ml) and an
Aβ42 level of 723 pg/ml (non-AD like) (local refer-
ence range: AD profile if <300 pg/ml). Screening
for MAPT mutations revealed a novel mutation
in exon 12 with a single heterozygous nucleotide
change c.1052A >G.
Presently, 13 years after initial presentation,
CW is profoundly amnesic. She is very repetitive
and her conversation is impoverished in content.
She gives the same highly stereotyped and very
restricted account of her childhood to everyone she
meets.
The latest neuropsychology assessment at the
age of 62 years showed general cognitive decline
(WASI-II FSIQ 86) (Wechsler, 2011). Working
memory as measured by digit span remained within
normal limits scaled score 10) (Wechsler, 1987).
Recognition memory was at chance. She had no
TABLE 2
Autobiographical memory interview at the age of 61 years old
(12-year follow-up visit)
Total score summary
Personal
semantic
Autobiographical
incidents
Section A childhood 5.5/21 0/9
Section B early adult life 10/21 2/9
Section C recent Life 4.5/21 0/9
20/63 (32%) 2/27 (7%)
Cut-off <47 <12
recall of a short story in immediate or delayed recall
conditions. Naming scores were progressively lower
across all tests (GNT now 0/30, Boston Naming
Test 18/30) (Kaplan, Goodglass, & Weintraub,
1983), with worsening semantic deterioration (ani-
mal names: 4, vegetable names: 0) also a feature.
Phonemic fluency was further reduced but execu-
tive function per se remained otherwise relatively
stable. On formal examination, recall of both per-
sonal semantic and autobiographic incidents was
impaired (Kopelman, Wilson, & Baddeley, 1989),
the latter more dramatically so (Table 2). Notably,
posterior function remained relatively intact (VOSP
object decision: >5% cut-off; complex figure copy:
25–50%). The profile thus remained one of pro-
found episodic and semantic memory loss with
less marked executive dysfunction but now in the
context of striking behavioral change.
Neurologically she now has evidence of mild
asymmetric parkinsonism and pyramidal signs.
There is a mild resting tremor in her left hand asso-
ciated with bradykinesia. She has pathologically
brisk reflexes in her right arm and leg, Hoffman’s
sign in her right hand and an extensor right planter.
Orofacial and limb praxis are normal.
NEUROIMAGING
As noted earlier, the first MRI brain scan at pre-
sentation (aged 49) was thought to show bilateral
medial temporal atrophy. More recent blinded radi-
ological review of these images also reported frontal
and parietal lobe atrophy (Figure 2). Subsequent
longitudinal MRI scans demonstrated progressive
global cerebral atrophy with particularly striking
changes in the anterior, inferior, and medial aspects
of the temporal lobes (Figures 1 and 2).
The pattern of these early temporal lobe changes
are more clearly demonstrated by whole brain
fluid registration (Figure 3). This method involves
nonlinear warping of each scan to match the
baseline scan, generating a deformation field that
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Figure 2. Spatially aligned coronal MR images from baseline (Bl), 4-year and 12-year follow-up visits demonstrating progressive atrophy
affecting frontal, temporal, and parietal lobes.
Figure 3. Representative coronal and sagittal MRI slices with voxel deformation mapping overlay, over an interval of 4 years post-
presentation. These demonstrate relatively focal bilateral contraction (green/blue = volume loss) in the temporal lobes, particularly
involving the temporal poles, parahippocampal and fusiform gyri, with an anterior–posterior gradient. [To view this figure in colour,
please see the online version of this Journal.]
allows visualization of voxel-level expansion and
contraction (Freeborough & Fox, 1998). These
images show clear evidence of progressive atro-
phy in the temporal lobes, frontal gyri, and
the insular cortices early in the disease process,
before it was detectable during routine radiological
assessment.
Given the novel mutation and the atypical clin-
ical presentation, we compared CW’s scans with
those of 9MAPT cases in our FTD cohort and
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13 healthy controls matched for age and gender.
All images underwent non-uniformity correction,
manual whole-brain delineation, and affine 12 d.o.f.
registration to quantify longitudinal whole brain
change. Hippocampal volumes were derived using
a template based method for automated segmenta-
tions (Cardoso et al., 2013) and used to investigate
longitudinal hippocampal volume change for CW
and the nine MAPT mutation cases with longi-
tudinal imaging. We generated a head size mea-
sure by estimating total intracranial volumes (TIV)
from the summation of the volumes of gray mat-
ter, white matter, and cerebral spinal fluid using
the segmentation toolbox in Statistical Parametric
Mapping version 8 (Wellcome Trust Centre for
Neuroimaging, London, UK, http://www.fil.ion.
ucl.ac.uk/spm; Leung et al., 2010).
CW’s early global longitudinal profile appeared
very stable with volumetric analysis revealing
whole-brain volumes that ranged from 1017 mm3
(75.9% of TIV) at baseline to 1004 mm3 (75.0% of
TIV) at 4-year follow-up (Figure 4). Between these
two time points, her average annual loss of 0.28%
of baseline whole-brain volume was comparable to
our controls (mean = 0.27%, SD = 0.32) T (12) =
0.05, p = .96 (Crawford & Howell, 1998) and was
also consistent with previously published rates for
healthy controls (mean 0.32%, 95% CI 0.1–0.54%)
(Scahill et al., 2003). Compared to the otherMAPT
mutation cases, her whole-brain atrophy rate at this
early stage was toward the lower end of the range
but was not significantly different (mean = 1.44%,
SD= 0.76, range= 0.20–2.53%) T (8)= −1.45, p =
.19. When compared to three of theMAPT cases of
similar disease duration, CW’s whole-brain atrophy
rate was again in the lower range. Her annualized
hippocampal rate of change over the same time
period (3.35%) was significantly higher than our
controls (mean = 0.30%, SD = 1.30) T (12) = 2.26,
p = .04 and was toward the higher end of the range
compared to the other MAPT mutation cases but
again not significantly different (mean = 2.16%,
SD = 2.25, range = –1.66–5.40%) T (8) = 0.50,
p = .63 (Figure 5). Her hippocampal atrophy rate,
however, was similar to those of the three MAPT
cases of comparable disease duration. Therefore,
CW’s hippocampal and whole-brain atrophy rates
were not atypical compared to other MAPT muta-
tion cases in our FTD cohort.
DISCUSSION
Here we report a novel MAPT mutation case in
exon 12 with a predominantly amnestic presen-
tation masquerading as AD initially. The muta-
tion causes a glutamine to arginine substitution
Figure 4. Longitudinal whole brain volumes (as percentage of total intracranial volume) for • MAPT mutation cases andCW against
disease duration. [To view this figure in colour, please see the online version of this Journal.]
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Figure 5. Longitudinal average hippocampal volumes (as percentage of total intracranial volume) for • MAPT mutation cases and 
CW against disease duration. [To view this figure in colour, please see the online version of this Journal.]
at codon 351 (Q351R) in the fourth microtubule
repeat domain with a PolyPhen-2 score of 0.891, i.e.
possibly damaging (Adzhubei et al., 2010). The sub-
stitution is likely to lead to reduced capacity of tau
protein to bind to microtubules and, or increased
fibrillogenicity (Hong et al., 1998; Spillantini, Van
Swieten, &Goedert, 2000). Given the long duration
of the case and the suggestion that disease severity
of MAPT mutations are in part related to the rel-
ative reduction of the ability of the tau protein to
interact with microtubules (Spillantini et al., 2000;
Van Swieten et al., 1999), in vivo studies assessing
tau functions in this mutation would be particularly
instructive.
The key clinical features ofMAPT mutations are
behavioral changes, semantic impairment, episodic
memory decline, and parkinsonism (Rohrer &
Warren, 2011). Although behavioral changes are
the prototypical presenting symptoms of MAPT
cases (Rohrer et al., 2011), any of the other non-
behavioral features may lead (Doran et al., 2007;
Ishizuka, Nakamura, Ichiba, & Sano, 2011; Larner,
2008; Rohrer et al., 2011). When episodic mem-
ory impairment is prominent, it is not uncommon
for AD to be diagnosed. This has been reported
for mutations involving both the coding regions
(Mirra et al., 1999) (Tolboom et al., 2010) and the
intronic regions (Doran et al., 2007; Larner, 2008).
As highlighted in a recent review (Hornberger
& Piguet, 2012), the magnitude of anterograde
memory deficits in FTD can be very similar to that
in AD. Our case illustrates this point and the impor-
tance of screening forMAPT mutations in families
with an autosomal dominant history of an amnes-
tic syndrome where mutations for familial AD have
proven negative (Larner, 2008).
It is well established that the same MAPT muta-
tion can give rise to different clinical phenotypes.
For example, the P301Lmutation has been reported
to present with amnesia, behavioral change, seman-
tic loss, or motor syndromes (Donker Kaat et al.,
2009; Ishizuka et al., 2011; Mirra et al., 1999; Van
Swieten et al., 1999). It has led to the sugges-
tion that molecular pathologies do not necessarily
specify a precise initial neuroanatomical locus of
damage (Rohrer et al., 2010); other factors such as
developmental vulnerability or environmental fac-
tors may possibly influence this (Mesulam, 2009).
It remains to be seen whether other clinical pheno-
types of the Q351R mutation would emerge in due
course.
A significant aspect of the current case was the
initial diagnostic difficulty. During the early years,
there was a suggestion of a significant functional
component to CW’s presentation. It was thought
that her very poor performance on tests of mem-
ory and confrontation naming were inconsistent
with her fluent, articulate speech and reasonable
account of day-to-day events. However, as nam-
ing deficits are very rarely a cognitive correlate
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of depression (Emery & Breslau, 1989), in retro-
spect, her reduced confrontation naming—present
even at the initial assessment—should have pointed
to a neurogenic cognitive impairment suggesting
early subtle semantic impairment which perhaps
should have raised the suspicion of a non-AD diag-
nosis at the time. As mentioned earlier, semantic
impairment is a frequent finding in cases ofMAPT
mutations (Rohrer & Warren, 2011; Seelaar et al.,
2008) and can be present early or even in the
presymptomatic phase of the illness (Garrard &
Carroll, 2005; Ishizuka et al., 2011). Early pro-
found anomia was also present in a family with
an intron 10 + 16 mutation, many of whom pre-
sented with amnestic symptoms (Doran et al.,
2007). Other evidence of semantic degradation
in CW, including reduced semantic fluency and
poor synonym-matching scores, emerged over time
(Table 1). Interestingly, apart from the observation
of poverty of speech content, no major concern
with her language function has been raised at any
time.
Similarly CW’s poor performance on the reten-
tion trials of the Gollin figure test was seen as
supportive evidence of a significant functional com-
ponent as it was assumed that even amnestic
patients would usually show some implicit learn-
ing (Warrington & Weiskrantz, 1968). The most
likely explanation is that her profoundly impaired
episodic memory system, together with weakened
support from the visual semantic system resulted
in an inability to support such implicit learning.
There is little doubt that other apparent discrepan-
cies between her scores on memory tests and her
clinical presentations were over emphasized. This
illustrates the difficulty in making such judgements
based on relatively brief clinical contact.
Both MRI and CSF played a role in making
the eventual diagnosis. Progressive medial tempo-
ral lobe atrophy along an anterior–posterior gra-
dient provided a useful diagnostic pointer (Chan
et al., 2001). Arguably, MR techniques such as fluid
registration allow more focal measurements and
regional visualization so could potentially detect
these changes before routine radiological review.
At the time of initial investigation and CSF exam-
ination, tau and Aβ42 protein assays were not
available. When reinvestigation—10 years later—
was prompted by the atypical clinical course and
the MRI findings, these assays had been established
and lent support to a non-AD pathology.
For the last few years, CW has given a very
circumscribed and highly stereotyped account of
her autobiographical history. Her extremely limited
repertoire of autobiographical accounts is unlike
that typically seen in patients with either AD or
semantic dementia (SD) (Graham & Hodges, 1997;
Leyhe, Müller, Milian, Eschweiler, & Saur, 2009)
and is likely to be the result of an interaction of
her impaired episodic and semantic memory sys-
tems with additional contribution from impaired
strategic retrieval mechanisms (Matuszewski et al.,
2006). Autobiographical memory (AbM) has both
an episodic component and a personal semantic
memory component (Tulving, 1993). In AD, per-
sonal semantics scores correlate with bilateral ante-
rior and posterior lateral temporal lobe volume and
episodic AbM scores correlate with combined atro-
phy in bilateral medial temporal lobes and anterior
lateral temporal neocortex (Gilboa et al., 2005).
The impairment CW shows in both components
of AbM is consistent with the neuroimaging find-
ings of severe temporal lobe atrophy involving the
anterior and medial aspects but also, to a lesser
extent, the lateral temporal cortex. In terms of a
temporal gradient, patients with early AD typi-
cally remember remote personal facts and incidents
better than recent ones (maintenance of the remi-
niscence bump and absence of the “recency” effect)
(Morris & Mograbi, 2013). The opposite pattern
is seen in early SD (Graham & Hodges, 1997;
Hou, Miller, & Kramer, 2005; Irish et al., 2011)
although as disease progresses, memory for all time
periods is degraded (Matuszewski et al., 2009).
Interestingly, CW appeared to have slightly better
recall of the AbM for early adulthood compared
with childhood and recent life, namely a relatively
preserved reminiscence bump, but with no other
temporal gradient in either direction. The auto-
biographical memory interview (Kopelman et al.,
1989) used in our study has a free recall and a
general probing condition. A more detailed pro-
cedure such as one that employs specific probes
could potentially yield more informative findings
(Irish et al., 2011). Systematic study of the orga-
nization of AbM in patients with genetic FTD is
needed to shed further light on this relatively little
investigated area.
CW’s serial volumetric MR images over a 12-
year period and fluid registration of her MRI brain
scans demonstrate a relatively symmetrical pattern
of atrophy affecting the frontal, temporal and, to a
lesser extent, parietal lobes with particular empha-
sis on the anterior, medial, and inferior aspects of
the temporal lobes (Figures 1–3). This concurs with
previous MRI findings of bilateral anteromedial
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temporal lobe involvement in MAPT mutation
(Rohrer et al., 2010 2011; Whitwell et al., 2009
2012). In contrast with Whitwell et al.’s findings
that mutations which affect the structure of the tau
protein preferentially involve the lateral temporal
lobes with relative sparing of the medial temporal
lobe (Whitwell et al., 2009), for this novel muta-
tion with putative defect in tau structure, the medial
temporal lobes are more atrophied.
The remarkably slow progression of this case is
instructive for the discussion on FTD phenocopy
syndrome (Kipps, Hodges, & Hornberger, 2010;
Piguet, Hornberger, Mioshi, & Hodges, 2011) and
suggests a need for caution in the diagnosis in
such cases. On the basis of the slow pace of pro-
gression, similar cases, particularly those led by
behavioral problems might have been diagnosed
as phenocopies. As noted earlier, compared with
other MAPT cases, during the early years, CW’s
whole-brain atrophy rate was toward the lower end
of the range whilst her hippocampal atrophy rate
was toward the higher end. This could suggest that
the overall rate of clinical progression may be bet-
ter correlated with the extent to which pathology
spreads outside the initial focus. A caveat of mak-
ing such comparisons with other MAPT mutation
cases is that we were limited by the number of cases
in the local FTD cohort with comparable disease
duration.
In conclusion, despite the initial atypical pre-
sentation of the case, subsequent development of
semantic deficits and behavioral changes as well as
the MRI atrophy patterns are consistent with exist-
ing literature on MAPT mutations. This supports
the hypothesis that in MAPT mutations, although
the initial target of the disease may be stochastic,
the subsequent propagation is likely to conform to
a specific, intrinsic brain network according to the
underlying molecular pathology (Warren, Rohrer,
& Hardy, 2012).
This case also illustrates a number of clinical
and neuropsychological issues: the significance of
anomia in the context of atypical amnesia in point-
ing toward a non-AD diagnosis; the value of search-
ing for a MAPT mutation in cases of early onset
dementia characterized by amnesia and relevant
family history with negative familial AD muta-
tions; the complexity in differentiating organic and
functional amnesia and the unique effect on auto-
biographical memory as a result of an interaction
between damaged episodic and semantic memory
systems.
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